There is good evidence to suggest that MYC oncogene expression and the telomere maintenance process in pediatric embryonal tumor cell populations are important in facilitating cell divisions required for cancer cell immortalized proliferation, thus making both of them attractive candidates for possible therapeutic targets. The gene discussed is MYC; the disease is cancer.